Visual acuity of children treated with chemotherapy for optic pathway gliomas

Pediatric Blood and Cancer

Volumn 61, Issue 2, 2014, Pages 223-227

  Kalin Hajdu, Evan ^a   Décarie, Jean Claude ^a   Marzouki, Monia ^a   Carret, Anne Sophie ^a   Ospina, Luis H ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Chemotherapy; Optic pathway glioma; Visual acuity

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; NEUROFIBROMIN; PROCARBAZINE; TIOGUANINE; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GENE MUTATION; HUMAN; MALE; MUTANT; OPTIC NERVE GLIOMA; OPTIC PATHWAY GLIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

EID: 84890886146     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24726     Document Type: Article

References (19)

1. Listernick R, Charrow J, Greenwald MJ, et al. Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1989; 114:788-792.
2. Singhal S, Birch JM, Kerr B, et al. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 2002; 87:65-70.
3. Mahoney DH, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: A pediatric oncology group phase II study. Neuro Oncol 2000; 2:213-220.
4. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997; 86:747-754.
5. Kelly JP, Leary S, Khanna P, et al. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 2012; 119:1231-1237.
6. Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: A multicenter retrospective analysis. Neuro Oncol 2012; 14:790-797.
7. Campagna M, Opocher E, Viscardi E, et al. Optic pathway glioma: Long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer 2010; 55:1083-1088.
8. Shofty B, Ben-Sira L, Freedman S, et al. Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer 2011; 57:481-485.
9. Dalla Via P, Opocher E, Pinello ML, et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol 2007; 9:430-437.
10. World F Health Organization. Consultation on development of standards for characterization of vision loss and visual functioning. Geneva: WHO; 2003; pp 4-5. September 2003, WHO document WHO/ICD-10/H54.
11. Nicolin G, Parkin P, Mabott D, et al. Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer 2009; 53:1231-1237.
12. Tow SL, Chandela S, Miller NR, et al. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2003; 28:262-270.
13. Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995; 75:1051-1059.
14. Varan A, Batu A, Cila A, et al. Optic glioma in children: A retrospective analysis of 101 cases. Am J Clin Oncol 2013; 36:287-292.
15. Laithier V, Grill J, Le Deley MC, et al. Progression-free survival in children with optic pathway tumors: Dependence on age and the quality of the response to chemotherapy-Results of the first French prospective study for the French society of pediatric oncology. J Clin Oncol 2003; 21:4572-4578.
16. Khafaga Y, Hassounah M, Kandil A, et al. Optic gliomas: A retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys 2003; 56:807-812.
17. Gayre GS, Scott IU, Feuer W, et al. Longterm visual outcome in patients with anterior visual pathway gliomas. J Neuroopthalmol 2001; 21:1-7.
18. Segal L, Darvish-Zargar M, Dilenge M-E, et al. Optic pathway gliomas in patients with neurofibromatosis type 1: Follow-up of 44 patients. J AAPOS 2010; 14:155-158.
19. Cotter SA, Tarczy-Hornoch K, Song E, et al. Fixation preference and VA testing in a population-based cohort of preschool children with amblyopia risk factors. Ophthalmology 2009; 116:145-153.